Wellington Management Group
IMNM icon

Wellington Management Group’s Immunome IMNM Stock Holding History

Wellington Management Group’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$103M Buy
4,731,977
+3,797,514
+406% +$84.5M 0.02% 545
2025
Q4 		$20.1M Buy
934,463
+680,395
+268% +$11.9M ﹤0.01% 1030
2025
Q3 		$2.98M Buy
254,068
+42,239
+20% +$420K ﹤0.01% 1552
2025
Q2 		$1.97M Buy
211,829
+58,818
+38% +$482K ﹤0.01% 1584
2025
Q1 		$1.03M Buy
153,011
+7,447
+5% +$71.4K ﹤0.01% 1703
2024
Q4 		$1.55M Buy
145,564
+4,874
+3% +$58.9K ﹤0.01% 1635
2024
Q3 		$2.06M Buy
140,690
+81,354
+137% +$1.16M ﹤0.01% 1534
2024
Q2 		$718K Buy
59,336
+4,587
+8% +$71.8K ﹤0.01% 1734
2024
Q1 		$1.35M Buy
+54,749
New +$1.11M ﹤0.01% 1615

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group's IMNM Position: Q1 2026 in Review

Wellington Management Group increased its Immunome (IMNM) stake by 406% in Q1 2026, buying an estimated $84.5M and bringing the position to 4,731,977 shares worth $103M. The position accounts for 0.02% of the portfolio, ranked #545.

Wellington Management Group first reported a position in IMNM in Q1 2024 and has held it in 9 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Wellington Management Group held 4,731,977 shares of Immunome worth $103M as of Q1 2026.
  • Wellington Management Group bought 3,797,514 Immunome shares in Q1 2026, an estimated $84.5M.
  • Immunome made up 0.02% of Wellington Management Group's portfolio in Q1 2026, its #545 holding.
  • Wellington Management Group first reported a position in Immunome in Q1 2024 and has held it in 9 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.